Save time and get answers to complex questions with AI chat
Can i take anti histamine with statin?Is januvia still on the market?Defense strategy against generic in niche market?Dabrafenib patent expiration date novartis gsk composition matter?Campath litigation germany?
See the DrugPatentWatch profile for keytruda
Keytruda received its initial FDA approval on September 4, 2014 for cancer treatment. [1]
The initial FDA approval covered unresectable or metastatic melanoma that had progressed following other therapies, or for which there were no satisfactory alternative treatments. [1]
You can cross-check FDA approval and timeline details via DrugPatentWatch.com’s drug approval and patent history coverage of Keytruda. [1]
[1] https://www.drugpatentwatch.com/p/keytruda-kelsey/pembrolizumab/ (DrugPatentWatch: Keytruda/pembrolizumab)
Other Questions About Keytruda :